Loading clinical trials...
Loading clinical trials...
This study aims to investigate the influence of a potential leg fluid shift (LFS) in patients with chronic heart failure (CHF) and obstructive sleep apnea (OSA) or central sleep apnea (CSA).
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Heart and Diabetes Center North-Rhine Westfalia
NCT04607343 · Obstructive Sleep Apnoea
NCT06376305 · Type 2 Diabetes, Obstructive Sleep Apnoea, and more
NCT01458613 · Lysosomal Storage Disease, Lung Diseases, and more
NCT02012868 · Obstructive Sleep Apnoea (OSA)
NCT02967536 · Obstructive Sleep Apnoea, Inflammation
Heart - and Diabetes CenteHerz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen
Bad Oeynhausen, North - Rhine Westfalia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions